Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors
Abstract
Purpose
Posttraumatic stress disorder (PTSD) is a severe anxiety disorder developed by exposure to any incident or circumstance that results in psychological trauma. In this study we compared the psychological and physiological changes between patients with malignant and benign breast tumors.
Methods
We selected 150 Chinese women with a breast mass, aged 20 to 45 years, from the Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital between 2009 and 2011 for this study; 30 healthy participants were enrolled into the control group. All subjects were examined and had their tumor mass aspirated for diagnosis. Equal numbers of patients with benign and malignant tumors were recruited. Patients with malignant tumors presented with low grade, minimal tumor invasion and non-involved lymph nodes. Questionnaires regarding anxiety, depression and PTSD were conducted 2 hours before getting the diagnostic result and 1 month after the diagnosis. Serum levels of IL-6, TNF-, cortisol and high-sensitivity C-reactive protein before and after diagnosis were investigated and compared. The number of occurrences of oral ulcerative mucositis was also recorded.
Results
All patients experienced a certain degree of anxiety and their biomarkers were elevated compared with the normal reference range before the pathological report was disclosed. However, 1 month after the operation, the benign tumor group showed significantly lower levels of biomarkers and anxiety scores than patients with a malignant breast tumor. The results were consistent throughout 12 months of study.
Conclusion
Study subjects with a benign tumor returned to their normal condition after being diagnosed, while patients with a malignant tumor suffered from a certain degree of PTSD or depression.
References
1. Glynn S.M., Shetty V. The long-term psychological sequelae of orofacial injury. Oral Maxillofac Surg Clin North Am 2010; 22: 217–24.
2. Johannesson K.B., Lundin T., Hultman C.M., Fröjd T., Michel P.O. Prolonged grief among traumatically bereaved relatives exposed and not exposed to a tsunami. J Trauma Stress 2011; 24: 456–64.
3. De Vries J., Van der Steeg A.F., Roukema J.A. Trait anxiety determines depressive symptoms and fatigue in women with an abnormality in the breast. Br J Health Psychol 2009; 14: 143–57.
4. Cheung F.Y., Mang O.W., Law S.C. A population-based analysis of incidence, mortality, and stage-specific survival of cervical cancer patients in Hong Kong: 1997–2006. Hong Kong Med J 2011; 17: 89–95.
5. Harrington C.B., Hansen J.A., Moskowitz M., Todd B.L., Feuerstein M. It's not over when it's over: long-term symptoms in cancer survivors–a systematic review. Int J Psychiatry Med 2010; 40: 163–81.
6. Cooper C.L., Cooper R., Faragher E.B. Incidence and perception of psychosocial stress: the relationship with breast cancer. Psychol Med 1989; 19: 415–22.
7. Butow P.N., Hiller J.E., Price M.A., Thackway S.V., Kricker A., Tennant C.C. Epidemiological evidence for a relationship between life events, coping style, and personality factors in the development of breast cancer. J Psychosom Res 2000; 49: 169–81.
8. Heim C., Nemeroff C.B. Neurobiology of posttraumatic stress disorder. CNS Spectr 2009; 14: 13–24.
9. Heim C., Shugart M., Craighead W.E., Nemeroff C.B. Neurobiological and psychiatric consequences of child abuse and neglect. Dev Psychobiol 2010; 52: 671–90.
10. Carrasco G.A., Van de Kar L.D. Neuroendocrine pharmacology of stress. Eur J Pharmacol 2003; 463: 235–72.
11. Karakoyun-Celik O., Gorken I., Sahin S., Orcin E., Alanyali H., Kinay M. Depression and anxiety levels in woman under follow-up for breast cancer: relationship to coping with cancer and quality of life. Med Oncol 2010; 27: 108–13.
12. Leung A.W., Mak J., Cheung P.S., Epstein R.J. Evidence for a programming effect of early menarche on the rise of breast cancer incidence in Hong Kong. Cancer Detect Prev 2008; 32: 156–61.
13. Yang L., Li L.D., Chen Y.D., Parkin D.M. Time trends, estimates and projects for breast cancer incidence and mortality in China. Zhonghua Zhong Liu Za Zhi 2006; 28: 438–40.
14. Montazeri A. Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007. J Exp Clin Cancer Res 2008; 27: 32.
15. Vahdaninia M., Omidvari S., Montazeri A. What do predict anxiety and depression in breast cancer patients? A follow-up study. Soc Psychiatry Psychiatr Epidemiol 2010; 45: 355–61.
16. Akechi T., Okuyama T., Imoto S., Yamawaki S., Uchitomi Y. Biomedical and psychosocial determinants of psychiatric morbidity among postoperative ambulatory breast cancer patients. Breast Cancer Res Treat 2001; 65: 195–202.
17. Okamura M., Yamawaki S., Akechi T., Taniguchi K., Uchitomi Y. Psychiatric disorders following first breast cancer recurrence: prevalence, associated factors and relationship to quality of life. Jpn J Clin Oncol 2005; 35: 302–9.
18. Wirsching M., Stierlin H., Hoffmann F., Weber G., Wirsching B. Psychological identification of breast cancer patients before biopsy. J Psychosom Res 1982; 26: 1–10.
19. Dillard A.J., McCaul K.D., Kelso PD, Klein W.M. Resisting good news: reactions to breast cancer risk communication. Health Commun 2006; 19: 115–23.
20. Rowland J.H., Desmond K.A., Meyerowitz B.E., Belin T.R., Wyatt G.E., Ganz P.A. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 2000; 92: 1422–9.
21. Silva S.M., Moreira H.C., Canavarro M.C. Examining the links between perceived impact of breast cancer and psychosocial adjustment: the buffering role of posttraumatic growth. Psychooncology 2012; 21: 409–18.
22. Vivar C.G. Psychosocial impact of breast cancer in long-term survival: proposal of an integral follow-up care for survivors. Aten Primaria 2012; 44: 288–92.
23. Figueroa-Moseley C., Jean-Pierre P., Roscoe J.A.et al. Behavioral interventions in treating anticipatory nausea and vomiting. J Natl Compr Canc Netw 2007; 5: 44–50.
24. Redd W.H., Montgomery G.H., DuHamel K.N. Behavioral intervention for cancer treatment side effects. J Natl Cancer Inst 2001; 93: 810–23.
25. Geracioti T.D. Jr, Baker D.G., Ekhator N.N.et al. CSF norepinephrine concentrations in posttraumatic stress disorder. Am J Psychiatry 2001; 158: 1227–30.
26. Piwowarska J., Wrzosek M., Radziwon-Zaleska M.et al. Serum cortisol concentration in patients with major depression after treatment with clomipramine. Pharmacol Rep 2009; 61: 604–11.
27. Elenkov I.J. Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being. Neurochem Int 2008; 52: 40–51.
28. Lanquillon S., Krieg J.C., Bening-Abu-Shach U., Vedder H. Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology 2000; 22: 370–9.
29. Schlatter J., Ortuño F., Cervera-Enguix S. Monocytic parameters in patients with dysthymia versus major depression. J Affect Disord 2004; 78: 243–7.
30. Gill J., Vythilingam M., Page G.G. Low cortisol, high DHEA, and high levels of stimulated TNF-alpha, and IL-6 in women with PTSD. J Trauma Stress 2008; 21: 530–9.
31. Cramer A.O., Waldorp L.J., van der Maas H.L., Borsboom D. Comorbidity: a network perspective. Behav Brain Sci 2010; 33: 137–50; discussion 150–93.
32. Dodd M.J., Dibble S., Miaskowski C.et al. A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 2001; 21: 498–505.
33. Loo W.T., Jin L.J., Chow L.W., Cheung M.N., Wang M. Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients? Expert Opin Investig Drugs 2010; 19 Suppl 1: S91–100.
34. Cheng K.K. Oral mucositis and quality of life of Hong Kong Chinese patients with cancer therapy. Eur J Oncol Nurs 2007; 11: 36–42.
35. Longmore M., Wilkinson I., Davidson E., Foulkes A., Mafi A. Oxford handbook of clinical medicine. Oxford: Oxford University Press, 2010.
36. Tsang T., Cheung K.F. Incidence and mortality trends of female breast cancer 1983–1999. Public health and epidemiology bulletin 2002; 11: 5.
37. Kmietowicz Z. Deaths from breast cancer fall dramatically in UK and US. BMJ 2000; 320: 1428A.
38. Trask P.C. Assessment of depression in cancer patients. J Natl Cancer Inst Monogr 2004; 32: 80–92.
39. Stark D., Kiely M., Smith A., Velikova G., House A., Selby P. Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol 2002; 20: 3137–48.
40. Kunzler A., Zindel A., Znoj H.J., Bargetzi M. Distress among cancer patients and their partners in the first year after diagnosis. Praxis (Bern 1994) 2010; 99: 593–9.
41. Bleiker E.M., Pouwer F., van der Ploeg H.M., Leer J.W., Adèr H.J. Psychological distress two years after diagnosis of breast cancer: frequency and prediction. Patient Educ Couns 2000; 40: 209–17.
42. Northouse L.L. Psychological impact of the diagnosis of breast cancer on the patient and her family. J Am Med Womens Assoc 1992; 47: 161–4.
43. Howren M.B., Lamkin D.M., Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosomatic Med 2009; 71: 171–86.
44. Miller G.E., Rohleder N., Stetler C., Kirschbaum C. Clinical depression and regulation of the inflammatory response during acute stress. Psychosomatic Med 2005; 67: 679–87.
45. Kiecolt-Glaser J.K., Glaser R. Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002; 53: 873–6.
46. Albanidou-Farmaki E., Poulopoulos A.K., Epivatianos A., Farmakis K., Karamouzis M., Antoniades D. Increased anxiety level and high salivary and serum cortisol concentrations in patients with recurrent aphthous stomatitis. Tohoku J Exp Med 2008; 214: 291–6.
47. Dorn L.D., Susman E.J., Petersen A.C. Cortisol reactivity and anxiety and depression in pregnant adolescents: a longitudinal perspective. Psychoneuroendocrinology 1993; 18: 219–39.
48. Conti C.M., Angelucci D., Ferri M.et al. Relationship between cancer and psychology: an updated history. J Biol Regul Homeost Agents 2011; 25: 331–9.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: January 15, 2018
Issue published: October-December 2012
Keywords
PubMed: 23250772
Authors
Metrics and citations
Metrics
Journals metrics
This article was published in The International Journal of Biological Markers.
VIEW ALL JOURNAL METRICSArticle usage*
Total views and downloads: 215
*Article usage tracking started in December 2016
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 7 view articles Opens in new tab
Crossref: 4
-
Return to work following meningioma surgery: a Swedish nationwide regi...
-
Psychological distress associated with active surveillance in patients...
-
A Pilot Study: Application of Hemoglobin and Cortisol Levels, and A ...
-
A Survey of Chinese Medicinal Herbal Treatment for Chemotherapy-Induce...
Figures and tables
Figures & Media
Tables
View Options
View options
PDF/ePub
View PDF/ePubGet access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
